To include your compound in the COVID-19 Resource Center, submit it here.

LifeMine, Cofactor raise $73M in series A

LifeMine Therapeutics Inc. (Cambridge, Mass.) and Cofactor Genomics Inc. (San Francisco, Calif.) each announced series A financings on Monday, raising a total of $73 million.

LifeMine raised

Read the full 263 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE